Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (13785)	6/4/2000 12:31:00 AM
From: Bluegreen	Respond to of 17367

Cacaito, repeat after me, BIOLOGICAL NEUPREX, BIOLOGICAL NEUPREX..........LOL I need another BIOLOGICAL in its league to compare it to. I need another antimicrobial peptide to compare it to. I won't even bring up safety profiles.<g> Methinks you are too obsessed with competition when evaluating products. You take a laughable position. Funny part is I think you are smart enough to know it is a laughable position!! Hatred for Xoma is clouding even that??? Last time I checked there was several billion people on this planet. In medicine and other businesses as you know there is no one perfect product for everyone. Just look at how many antibiotics are on the market. Just look at how many antidepressants are on the market. Just look at how many antihistamines are on the market. Just look at how many blood pressure lowering agents are on the market. Cholesterol lowing agents?? How many clot busters??? I could go on and on. Besides shouldn't we let Baxter Allergan and Genentech worry about competition in a GLOBAL ECONOMY???? Neuprex, A SAFE BIOLOGICAL in a GLOBAL ECONOMY IF APPROVED. Cacaito, as always appreciate the vigorous discussion.